Avadel Pharmaceuticals PLC (AVDL.OQ)
Get access to over 18 million research reports from over 1,700 sources.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
- private equity
- third-party document and information retrieval
- and much, much more…
|71||2014||Non-Executive Independent Chairman of the Board|
|68||2012||Chief Executive Officer, Director|
|53||2015||Senior Vice President, Chief Financial Officer|
|50||2017||Executive Vice President, Chief Commercial Officer|
|42||2013||Senior Vice President, General Counsel, Corporate Secretary|
- BRIEF-Avadel Pharma Q3 adjusted earnings per share $0.09
- BRIEF-Avadel Pharmaceuticals Plc says Avadel licensee and Serenity amended exclusivity agreement on Sept 1
- BRIEF-Avadel Pharmaceuticals Plc enters into a license agreement with Serenity Pharmaceuticals Llc
- BRIEF-Avadel Pharmac enters into negotiations with Serenity Pharma for Noctiva
- BRIEF-Avadel Pharmaceuticals reports Q2 GAAP earnings per share $0.68